PSORT is funded by a grant from the MRC to CI Chris Griffiths and team.
It is a stratified medicine consortium formed by world leading dermatologists, industry partners including pharmaceutical companies and psoriasis patients. Psoriasis is a chronic skin condition which affects more than 1.8 million people in the UK and can have a major impact of quality of life. The overall research strategy is to identify stratifiers of response to biologic therapies for patients with psoriasis.
You can find out more from PSORT’s website, or from it’s award page.